Milbank Intellectual Property and Litigation partner David Gindler will present “Is Innovation Enough: New Challenges to Patent Protection for Pharmaceuticals and Biologics” at the 2019 Life Sciences Patent Network North America Fall Conference on October 16 in San Francisco, California.
Attendees, including in-house patent counsel, will come together to hear updates on patent prosecution and enforceability from global jurisdictions, meet in informal discussion groups, and source specialist IP attorneys who can assist them with their IP portfolio strategies over the coming year.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
